JP2021080230A - Topical skin preparation - Google Patents
Topical skin preparation Download PDFInfo
- Publication number
- JP2021080230A JP2021080230A JP2019211417A JP2019211417A JP2021080230A JP 2021080230 A JP2021080230 A JP 2021080230A JP 2019211417 A JP2019211417 A JP 2019211417A JP 2019211417 A JP2019211417 A JP 2019211417A JP 2021080230 A JP2021080230 A JP 2021080230A
- Authority
- JP
- Japan
- Prior art keywords
- solid spherical
- mass
- skin
- particles
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 230000000699 topical effect Effects 0.000 title abstract 3
- 239000002245 particle Substances 0.000 claims abstract description 56
- 239000007787 solid Substances 0.000 claims abstract description 50
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 17
- 229920000642 polymer Polymers 0.000 claims abstract description 17
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 150000004676 glycans Chemical class 0.000 claims abstract description 7
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 7
- 239000005017 polysaccharide Substances 0.000 claims abstract description 7
- 229920000058 polyacrylate Polymers 0.000 claims abstract description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 58
- 239000011787 zinc oxide Substances 0.000 claims description 28
- 239000010419 fine particle Substances 0.000 claims description 9
- 230000000052 comparative effect Effects 0.000 description 16
- 239000011575 calcium Substances 0.000 description 12
- -1 cetyl hydroxyethyl Chemical group 0.000 description 12
- 229920001577 copolymer Polymers 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 210000002374 sebum Anatomy 0.000 description 5
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000000245 forearm Anatomy 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229910044991 metal oxide Inorganic materials 0.000 description 4
- 150000004706 metal oxides Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- WAUOHBVKOUNIAX-UHFFFAOYSA-N 2-(dimethylamino)-3-oxopent-4-ene-1-sulfonic acid Chemical class OS(=O)(=O)CC(N(C)C)C(=O)C=C WAUOHBVKOUNIAX-UHFFFAOYSA-N 0.000 description 2
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- NWGAAWUUGRXXSC-UHFFFAOYSA-N 1-(2-hydroxypropoxy)propan-2-yl 2-hydroxybenzoate Chemical compound CC(O)COCC(C)OC(=O)C1=CC=CC=C1O NWGAAWUUGRXXSC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- ALBXRBNFWICCSC-UHFFFAOYSA-N 2-(5,5-dimethyl-1,1-diphenylhex-1-en-3-ylidene)propanedioic acid Chemical compound C=1C=CC=CC=1C(=CC(CC(C)(C)C)=C(C(O)=O)C(O)=O)C1=CC=CC=C1 ALBXRBNFWICCSC-UHFFFAOYSA-N 0.000 description 1
- FRGIOIALHUOUTR-UHFFFAOYSA-N 2-[4-(diethylamino)-2-hydroxybenzoyl]hexyl benzoate Chemical compound C=1C=C(N(CC)CC)C=C(O)C=1C(=O)C(CCCC)COC(=O)C1=CC=CC=C1 FRGIOIALHUOUTR-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- DWYHDSLIWMUSOO-UHFFFAOYSA-N 2-phenyl-1h-benzimidazole Chemical class C1=CC=CC=C1C1=NC2=CC=CC=C2N1 DWYHDSLIWMUSOO-UHFFFAOYSA-N 0.000 description 1
- UMZUDTDSLXBKSI-UHFFFAOYSA-N 4-(2-butyl-3,4,5,6-tetramethylphenoxy)-2h-benzotriazole Chemical compound CCCCC1=C(C)C(C)=C(C)C(C)=C1OC1=CC=CC2=C1N=NN2 UMZUDTDSLXBKSI-UHFFFAOYSA-N 0.000 description 1
- BVNWQSXXRMNYKH-UHFFFAOYSA-N 4-phenyl-2h-benzotriazole Chemical class C1=CC=CC=C1C1=CC=CC2=C1NN=N2 BVNWQSXXRMNYKH-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical group OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- ULGYAEQHFNJYML-UHFFFAOYSA-N [AlH3].[Ca] Chemical compound [AlH3].[Ca] ULGYAEQHFNJYML-UHFFFAOYSA-N 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 229960002709 amiloxate Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 150000008316 benzisoxazoles Chemical class 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229940111759 benzophenone-2 Drugs 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005234 chemical deposition Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- CBZHHQOZZQEZNJ-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxypropyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC(C)O)CC(C)O)C=C1 CBZHHQOZZQEZNJ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- AZIQALWHRUQPHV-UHFFFAOYSA-N prop-2-eneperoxoic acid Chemical compound OOC(=O)C=C AZIQALWHRUQPHV-UHFFFAOYSA-N 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical class O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、化粧料などの皮膚外用剤に関し、より詳しくは、べたつきがなく使用感が良好な皮膚外用剤に関する。 The present invention relates to an external preparation for skin such as a cosmetic, and more particularly to an external preparation for skin that is not sticky and has a good usability.
化粧品や医薬部外品、医薬品などの皮膚外用剤においては、製品の安定性を保つなどの目的で親水性高分子が配合されている。(特許文献1〜6参照) In cosmetics, quasi-drugs, and external preparations for skin such as pharmaceuticals, hydrophilic polymers are blended for the purpose of maintaining product stability. (See Patent Documents 1 to 6)
しかしながら、親水性高分子は優れた安定性改善効果を有する反面、使用感触がべたついたものになりやすいことにより、親水性高分子を配合した製剤はともすれば消費者から嫌われることが多く、皮膚外用剤、特に化粧料に配合することにおいては、大きな難点となっていた。 However, while hydrophilic polymers have an excellent effect of improving stability, they tend to be sticky to the touch, so formulations containing hydrophilic polymers are often disliked by consumers. It has been a big difficulty in blending with external skin preparations, especially cosmetics.
また、中実ガラスを化粧料に配合することが知られていた(特許文献7参照)が、中実ガラスを配合することにより、親水性高分子によるべたつきを軽減することは知られていなかった。 Further, it has been known that solid glass is blended in cosmetics (see Patent Document 7), but it has not been known that blending solid glass reduces stickiness due to a hydrophilic polymer. ..
親水性高分子によるべたつきがなく、使用感の良好な皮膚外用剤を提供することを課題とする。 An object of the present invention is to provide an external preparation for skin that is not sticky due to a hydrophilic polymer and has a good usability.
本発明者らは、かかる課題について鋭意検討した結果、本発明を完成するにいたった。すなわち本発明は、下記のとおりである。
(1)
アクリル系高分子、ウレタン系高分子及び多糖系高分子から選択される1種又は2種以上の親水性高分子と、中実球状ホウケイ酸塩粒子とを含有することを特徴とする皮膚外用剤。
(2)
中実球状ホウケイ酸塩粒子が、微粒子酸化亜鉛被覆中実球状ホウケイ酸塩粒子である、(1)に記載の皮膚外用剤。
As a result of diligent studies on such a problem, the present inventors have completed the present invention. That is, the present invention is as follows.
(1)
An external preparation for skin, which contains one or more hydrophilic polymers selected from an acrylic polymer, a urethane polymer, and a polysaccharide polymer, and solid spherical borosilicate particles. ..
(2)
The skin external preparation according to (1), wherein the solid spherical borosilicate particles are fine particle zinc oxide-coated solid spherical borosilicate particles.
本発明の皮膚外用剤は、親水性高分子によるべたつきがなく、使用感が良好であるという効果を発揮する。 The external preparation for skin of the present invention exhibits the effect that it is not sticky due to the hydrophilic polymer and has a good usability.
以下、本発明を実施するための形態について詳細に説明する。ただし、本発明は以下の実施形態に限定されるものではない。 Hereinafter, embodiments for carrying out the present invention will be described in detail. However, the present invention is not limited to the following embodiments.
本発明の皮膚外用剤は、アクリル系高分子、ウレタン系高分子及び多糖系高分子から選択される1種又は2種以上の親水性高分子を含有する。 The external preparation for skin of the present invention contains one or more hydrophilic polymers selected from acrylic polymers, urethane polymers and polysaccharide polymers.
アクリル酸系高分子は、アクリル基構造を有しているもので、化粧料として使用可能であればよく、特に限定されない。例えば、(アクリレーツ/アクリル酸アルキル(C10−30))クロスポリマー、カルボマー、(アクリル酸Na/アクリロイルジメチルタウリン/ジメチルアクリルアミド)クロスポリマー、アクリルアミド−2−メチルプロパンスルホン酸塩共重合体、アクリル酸ヒドロキシエチル・アクリロイルジメチルタウリン塩共重合体、アクリル酸塩・アクリロイルジメチルタウリン共重合体、アクリル酸アミド・アクリル酸−2−メチルプロパンスルホン酸塩共重合体、アクリロイルジメチルタウリン塩・ビニルピロリドン共重合体などが挙げられる。
(アクリレーツ/アクリル酸アルキル(C10−30))クロスポリマーの市販例としては、ルーブリゾール社製のPEMULEN TR−1、PEMULEN TR−2、カーボポール 1342、カーボポール ETD2020、カーボポール ULTREZ−20、カーボポール ULTREZ−22、住友精化社製のAQUPEC HV−501ER、AQUPEC HV−701EDR、AQUPEC HV−801ERK、AQUPEC HV−803ERK、AQUPEC SW−703ER、AQUPEC SR−705ER等が挙げられる。
カルボマーの市販例としては、ルーブリゾール社製のカーボポール934、カーボポール940、カーボポール941、カーボポールETD2050、住友精化社製のAQUPEC HV−501E、AQUPEC HV−505E、AQUPEC HV−505ED、AQUPEC HV−801EG−300、AQUPEC HV−805EG−300、和光純薬社製のハイビスワコー103、ハイビスワコー104、ハイビスワコー105等が挙げられる。
(アクリル酸Na/アクリロイルジメチルタウリン/ジメチルアクリルアミド)クロスポリマー、アクリルアミド−2−メチルプロパンスルホン酸塩共重合体、アクリル酸ヒドロキシエチル・アクリロイルジメチルタウリン塩共重合体、アクリル酸塩・アクリロイルジメチルタウリン共重合体、アクリル酸アミド・アクリル酸−2−メチルプロパンスルホン酸塩共重合体、アクリロイルジメチルタウリン塩・ビニルピロリドン共重合体の市販例としては、SEPIC社製のSIMULGELシリーズ、SEPINOVシリーズ等が挙げられる。
The acrylic acid-based polymer has an acrylic group structure and is not particularly limited as long as it can be used as a cosmetic. For example, (Acrylate / alkyl acrylate (C10-30)) crosspolymer, carbomer, (Na acrylate / acryloyldimethyltaurine / dimethylacrylamide) crosspolymer, acrylamide-2-methylpropanesulfonate copolymer, hydroxyacrylate. Ethyl / acryloyldimethyltaurine salt copolymer, acrylate / acryloyldimethyltaurin copolymer, acrylic acid amide / acrylic acid-2-methylpropanesulfonate copolymer, acryloyldimethyltaurine salt / vinylpyrrolidone copolymer, etc. Can be mentioned.
(Acrylate / Alkyl Acrylate (C10-30)) Commercial examples of cross-polymers include PEMULEN TR-1, PEMULEN TR-2, Carbopole 1342, Carbopole ETD2020, Carbopole ULTREZ-20, and Carbo manufactured by Lubrizol. Examples thereof include Paul ULTREZ-22, AQUAPEC HV-501ER manufactured by Sumitomo Seika Chemical Co., Ltd., AQUAPEC HV-701EDR, AQUAPEC HV-801ERK, AQUAPEC HV-803ERK, AQUAPEC SW-703ER, and AQUAPEC SR-705ER.
Examples of commercially available carbomer include Carbopole 934, Carbopole 940, Carbopole 941, Carbopole ETD2050 manufactured by Lubrizol, AQPEC HV-501E, AQPEC HV-505E, AQPEC HV-505ED, and AQPEC manufactured by Sumitomo Seika Chemical Co., Ltd. Examples thereof include HV-801EG-300, AQUAPEC HV-805EG-300, Hibiswaco 103, Hibiswaco 104 and Hibiswaco 105 manufactured by Wako Junyaku Co., Ltd.
(Na acrylate / acryloyldimethyltaurine / dimethylacrylamide) Crosspolymer, acrylamide-2-methylpropanesulfonate copolymer, hydroxyethyl acrylate / acryloyldimethyltaurine salt copolymer, acrylate / acryloyldimethyltaurine copolymer Commercially available examples of the coalesced polymer, acrylate / acrylate-2-methylpropanesulfonate copolymer, and acryloyldimethyltaurine salt / vinylpyrrolidone copolymer include SIMULGEL series and SEPINOV series manufactured by SEPIC.
ウレタン系高分子は、皮膚外用剤に配合し得る水溶性のウレタン系高分子であれば特に限定されない。係るウレタン系高分子として、好ましくは疎水変性ポリエーテルウレタンを用いる。疎水変性ポリエーテルウレタンとしては、例えば、ポリエチレングリコール(PEG)−240/デシルテトラデセス−20/ヘキサメチレンジイソシアネート(HDI)コポリマー等が挙げられる。このPEG−240/デシルテトラデセス−20/HDIコポリマーの市販品としては、ADEKA社製のアデカノールGT−700が例示できる。 The urethane-based polymer is not particularly limited as long as it is a water-soluble urethane-based polymer that can be blended with an external preparation for skin. As the urethane-based polymer, a hydrophobically modified polyether urethane is preferably used. Examples of the hydrophobically modified polyether urethane include polyethylene glycol (PEG) -240 / decyltetradeceth-20 / hexamethylene diisocyanate (HDI) copolymer. As a commercially available product of this PEG-240 / decyltetradeceth-20 / HDI copolymer, ADEKA's Adecanol GT-700 can be exemplified.
多糖系高分子は、皮膚外用剤に配合し得る水溶性の多糖系高分子であれば特に限定されない。係る多糖系高分子としては、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系増粘剤、ヒドロキシプロピルメチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルセルロース、セチルヒドロキシエチルセルロース、メチルヒドロキシエチルセルロース、ヒドロキシエチルエチルセルロース、メチルヒドロキシプロピルセルロース、カルボキシメチルヒドロキシエチルセルロース等のセルロース系増粘剤、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系増粘剤、グアーガム、アラビアガム、カラヤガム、ジェランガム、寒天、カラギーナン、ペクチン、カルボキシメチルキトサン、プルラン、ヒドロキシエチルキトサン、カルボキシメチルデキストラン、コーンスターチ、デキストリン等が例示される。 The polysaccharide polymer is not particularly limited as long as it is a water-soluble polysaccharide polymer that can be blended with an external preparation for skin. Examples of the polysaccharide-based polymer include alginate-based thickeners such as sodium alginate and propylene glycol alginate, hydroxypropylmethyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, methyl cellulose, cetyl hydroxyethyl cellulose, methyl hydroxyethyl cellulose, and hydroxyethyl ethyl cellulose. , Cellulose thickeners such as methyl hydroxypropyl cellulose and carboxymethyl hydroxyethyl cellulose, starch thickeners such as carboxymethyl starch and methyl hydroxypropyl starch, guar gum, Arabic gum, Karaya gum, gellan gum, agar, carrageenan, pectin, carboxy Examples thereof include methyl chitosan, purulan, hydroxyethyl chitosan, carboxymethyl dextran, corn starch, and dextrin.
親水性高分子の配合量は、皮膚外用剤全量に対し、0.0001質量%以上が好ましく、0.001質量%以上がさらに好ましく、3質量%以下が好ましく1質量%以下がより好ましく、0.0001質量%以上3質量%以下が好ましく、0.001質量%以上1質量%以下がより好ましい。 The blending amount of the hydrophilic polymer is preferably 0.0001% by mass or more, more preferably 0.001% by mass or more, preferably 3% by mass or less, more preferably 1% by mass or less, and 0. It is preferably .0001% by mass or more and 3% by mass or less, and more preferably 0.001% by mass or more and 1% by mass or less.
本発明の皮膚外用剤は、中実球状ホウケイ酸塩粒子を含む。
中実球状ホウケイ酸塩粒子の平均粒子径は、0.1μm以上が好ましく、1μm以上がより好ましく、5μm以上がさらに好ましく、7μm以上が一層好ましい。また、中実球状ホウケイ酸塩粒子の平均粒子径は、20μm以下が好ましく、15μm以下がより好ましく、13μm以下がさらに好ましい。例えば、中実球状ホウケイ酸塩粒子の平均粒子径は、べたつき軽減効果の観点から、好ましくは1〜20μmであり、より好ましくは5〜15μmであり、さらに好ましくは7〜13μmである。なお、中実球状ホウケイ酸塩粒子の平均粒子径は、粉体粒子の形状に合わせ、顕微鏡法の原理により個数平均の平均粒子径として測定することができる。
The external preparation for skin of the present invention contains solid spherical borosilicate particles.
The average particle size of the solid spherical borosilicate particles is preferably 0.1 μm or more, more preferably 1 μm or more, further preferably 5 μm or more, and even more preferably 7 μm or more. The average particle size of the solid spherical borosilicate particles is preferably 20 μm or less, more preferably 15 μm or less, and even more preferably 13 μm or less. For example, the average particle size of the solid spherical borosilicate particles is preferably 1 to 20 μm, more preferably 5 to 15 μm, and further preferably 7 to 13 μm from the viewpoint of the stickiness reducing effect. The average particle size of the solid spherical borosilicate particles can be measured as the average particle size of the number average according to the principle of microscopy according to the shape of the powder particles.
中実球状ホウケイ酸塩粒子において、ホウケイ酸塩は、Na、K等のアルカリ金属塩、Mg、Ca等アルカリ土類金属塩、Al塩、又はこれらの塩の組み合わせであってよい。好ましくは、ホウケイ酸Na、ホウケイ酸Ca、ホウケイ酸Al、ホウケイ酸(Ca/Na)、ホウケイ酸(Ca/Al)であり、より好ましくはホウケイ酸(Ca/Na)である。
中実球状ホウケイ酸塩粒子は、化粧品表示名称(INCI名称)としては、ホウケイ酸(Ca/Na)(CALCIUM SODIUM BOROSILICATE)、ホウケイ酸(Ca/Al)(CALCIUM ALUMINUM BOROSILICATE)等と表示されるが、本発明においてはいずれの表示名称の中実球状ホウケイ酸塩粒子を用いてもよく、ホウケイ酸(Ca/Na)を用いることがより好ましい。
In the solid spherical borosilicate particles, the borosilicate may be an alkali metal salt such as Na or K, an alkaline earth metal salt such as Mg or Ca, an Al salt, or a combination thereof. It is preferably Na borosilicate, Ca borosilicate, Al borosilicate, borosilicate (Ca / Na), borosilicate (Ca / Al), and more preferably borosilicate (Ca / Na).
The solid spherical borosilicate particles are displayed as borosilicate (Ca / Na) (CALCIUM SODIUM BOROSILICATE), borosilicate (Ca / Al) (CALCIUM ALUMINUM BOROSILICATE), etc. as cosmetic labeling names (INCI name). In the present invention, solid spherical borosilicate particles having any display name may be used, and it is more preferable to use borosilicate (Ca / Na).
中実球状ホウケイ酸塩粒子の配合量は特に限定されないが、皮膚外用剤全量に対し、0.01質量%以上が好ましく、0.1質量%以上がより好ましく、1質量%以上がさらに好ましい。また、中実球状ホウケイ酸塩粒子の配合量は特に限定されないが、皮膚外用剤全量に対し、30質量%以下が好ましく、20質量%以下がより好ましく、10質量%以下がさらに好ましい。
例えば、中実球状ホウケイ酸塩粒子の配合量は、皮膚外用剤全量に対し、0.01〜30質量%が好ましく、より好ましくは0.1〜20質量%であり、さらに好ましくは1〜10質量%である。例えば、水媒体又は油媒体の剤型の皮膚外用剤では、中実球状ホウケイ酸塩粒子は、皮膚外用剤全量に対し0.01〜10質量%がさらに好ましい。また、粉末状又は固形状の剤型の皮膚外用剤では、中実球状ホウケイ酸塩粒子は、皮膚外用剤全量に対し0.1〜20質量%がさらに好ましい。
The blending amount of the solid spherical borosilicate particles is not particularly limited, but is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, still more preferably 1% by mass or more, based on the total amount of the external preparation for skin. The blending amount of the solid spherical borosilicate particles is not particularly limited, but is preferably 30% by mass or less, more preferably 20% by mass or less, still more preferably 10% by mass or less, based on the total amount of the external preparation for skin.
For example, the blending amount of the solid spherical borosilicate particles is preferably 0.01 to 30% by mass, more preferably 0.1 to 20% by mass, and further preferably 1 to 10 with respect to the total amount of the external preparation for skin. It is mass%. For example, in a water-based or oil-based dosage form for external skin preparation, the solid spherical borosilicate particles are more preferably 0.01 to 10% by mass based on the total amount of the external preparation for skin. Further, in the powdery or solid dosage form of the external preparation for skin, the solid spherical borosilicate particles are more preferably 0.1 to 20% by mass based on the total amount of the external preparation for skin.
中実球状ホウケイ酸塩粒子は未処理のものを用いてもよいし、親水化処理、又は疎水化処理を施したものを用いてもよい。 The solid spherical borosilicate particles may be untreated, or may be hydrophilized or hydrophobized.
本発明の中実球状ホウケイ酸塩粒子を皮膚外用剤に配合する場合、酸化亜鉛を被覆した酸化亜鉛被覆中実球状ホウケイ酸塩粒子とすることにより、皮脂固化効果を発揮し、化粧持ちを向上させることができる。 When the solid spherical borosilicate particles of the present invention are blended with an external preparation for skin, by using zinc oxide-coated solid spherical borosilicate particles coated with zinc oxide, a sebum solidifying effect is exhibited and makeup retention is improved. Can be made to.
本発明の酸化亜鉛被覆中実球状ホウケイ酸塩粒子に用いられる酸化亜鉛は、皮膚外用剤に配合し得るものであれば特に限定されない。酸化亜鉛の形状は特に限定されない。酸化亜鉛の平均粒子径は、皮脂固化能の観点より、10〜200nmが好ましく、15〜100nmがより好ましく、さらには15〜50nmが一層好ましい。なお、酸化亜鉛の平均粒子径は、体積基準の平均粒子径であり、レーザー回折・散乱式粒度分布測定装置により測定することができる。 The zinc oxide used in the zinc oxide-coated solid spherical borosilicate particles of the present invention is not particularly limited as long as it can be blended with an external preparation for skin. The shape of zinc oxide is not particularly limited. The average particle size of zinc oxide is preferably 10 to 200 nm, more preferably 15 to 100 nm, and even more preferably 15 to 50 nm from the viewpoint of sebum solidifying ability. The average particle size of zinc oxide is a volume-based average particle size, and can be measured by a laser diffraction / scattering type particle size distribution measuring device.
酸化亜鉛被覆中実球状ホウケイ酸塩粒子は、例えば、中実球状ホウケイ酸塩粒子を酸化亜鉛粉末によって被覆することによって得ることができる。酸化亜鉛粉末には、微粒子酸化亜鉛粒子を用いることが好ましい。
酸化亜鉛は未処理の酸化亜鉛をそのまま用いることもできるが、疎水化処理を施した酸化亜鉛を用いることが好ましい。疎水化処理剤としては特に限定されるものではなく、ジメチコン、メチルハイドロジェンポリシロキサン、金属石鹸等が例示される。これらの疎水化処理剤の中でも、ジメチコンを用いることが好ましい。疎水化処理剤の被覆量は酸化亜鉛を疎水化処理するのに十分な量であればよい。具体的には酸化亜鉛と疎水化処理剤の質量比が85:15〜99:1が好ましく、さらには90:10〜98:2が好ましい。
The zinc oxide-coated solid spherical borosilicate particles can be obtained, for example, by coating the solid spherical borosilicate particles with zinc oxide powder. It is preferable to use fine particles of zinc oxide as the zinc oxide powder.
As the zinc oxide, untreated zinc oxide can be used as it is, but it is preferable to use zinc oxide that has been hydrophobized. The hydrophobizing agent is not particularly limited, and examples thereof include dimethicone, methylhydrogenpolysiloxane, and metal soap. Among these hydrophobizing agents, it is preferable to use dimethicone. The coating amount of the hydrophobizing agent may be an amount sufficient for hydrophobizing zinc oxide. Specifically, the mass ratio of zinc oxide to the hydrophobizing agent is preferably 85: 15-99: 1, and more preferably 90: 10-98: 2.
本発明の皮膚外用剤に用いられる酸化亜鉛被覆中実球状ホウケイ酸塩粒子において、中実球状ホウケイ酸塩粒子1質量部に対し、酸化亜鉛の被覆量は0.01質量部以上が好ましく、0.05質量部以上がより好ましい。また、中実球状ホウケイ酸塩粒子1質量部に対し、酸化亜鉛の被覆量は2質量部以下が好ましく、1.5質量部以下がより好ましい。この範囲で、皮脂固化能をより高めて、皮脂崩れをより防止することができる。
中実球状ホウケイ酸塩粒子1質量部に対し、酸化亜鉛の被覆量は0.01〜2質量部が好ましく、0.05〜1.5質量部がより好ましい。
In the zinc oxide-coated solid spherical borosilicate particles used for the external preparation for skin of the present invention, the coating amount of zinc oxide is preferably 0.01 part by mass or more with respect to 1 part by mass of the solid spherical borosilicate particles, and is 0. More preferably, it is 0.05 parts by mass or more. Further, the coating amount of zinc oxide is preferably 2 parts by mass or less, and more preferably 1.5 parts by mass or less with respect to 1 part by mass of the solid spherical borosilicate particles. In this range, the sebum solidifying ability can be further enhanced and sebum collapse can be further prevented.
The amount of zinc oxide coated is preferably 0.01 to 2 parts by mass, more preferably 0.05 to 1.5 parts by mass with respect to 1 part by mass of the solid spherical borosilicate particles.
中実球状ホウケイ酸塩への酸化亜鉛の被覆方法としては、これまで知られた各種方法を用いることができ、例えば、物理化学的な混合摩砕法(乾式、湿式)、化学的な沈着法等を用いることができる。酸化亜鉛被覆中実球状ホウケイ酸塩粒子の皮脂固化能の点から、乾式の混合摩砕法を好ましく用いることができる。 As a method for coating solid spherical borosilicate with zinc oxide, various methods known so far can be used, for example, a physicochemical mixed grinding method (dry or wet), a chemical deposition method, or the like. Can be used. From the viewpoint of the sebum solidifying ability of the zinc oxide-coated solid spherical borosilicate particles, a dry mixed grinding method can be preferably used.
本発明の皮膚外用剤は、上記した中実球状ホウケイ酸塩粒子、好ましくは酸化亜鉛被覆中実球状ホウケイ酸塩粒子を含むことによって、皮脂固化能を有し、優れた化粧持ち効果を発揮することができる。 The external preparation for skin of the present invention has a sebum-solidifying ability and exhibits an excellent cosmetic lasting effect by containing the above-mentioned solid spherical borosilicate particles, preferably zinc oxide-coated solid spherical borosilicate particles. be able to.
本発明の皮膚外用剤において、親水性高分子及び中実球状ホウケイ酸塩粒子の合計量は、皮膚外用剤全量に対し、0.1〜10質量%が好ましく、1〜8質量%がより好ましい。本発明の皮膚外用剤において、親水性高分子1質量部に対し、中実球状ホウケイ酸塩粒子は、0.01〜1質量部が好ましく、0.05〜0.5質量部が好ましい。この範囲で、親水性高分子による作用を得ながら、皮膚外用剤のべたつき及び化粧持ちを改善することができる。 In the external preparation for skin of the present invention, the total amount of the hydrophilic polymer and the solid spherical borosilicate particles is preferably 0.1 to 10% by mass, more preferably 1 to 8% by mass, based on the total amount of the external preparation for skin. .. In the external preparation for skin of the present invention, the solid spherical borosilicate particles are preferably 0.01 to 1 part by mass, preferably 0.05 to 0.5 part by mass with respect to 1 part by mass of the hydrophilic polymer. Within this range, it is possible to improve the stickiness and long-lasting makeup of the external preparation for skin while obtaining the action of the hydrophilic polymer.
本発明の皮膚外用剤には、水性成分を含有する。かかる水性成分としては、例えば、水、上記以外の親水性高分子、保湿剤、防腐剤、分散剤、pH調整剤、消泡剤、保湿剤等が挙げられる。 The external preparation for skin of the present invention contains an aqueous component. Examples of such an aqueous component include water, hydrophilic polymers other than the above, moisturizers, preservatives, dispersants, pH adjusters, defoamers, moisturizers and the like.
本発明の皮膚外用剤は、金属酸化物微粒子や有機紫外線吸収剤を配合することにより、日焼け止め化粧料として使用することができる。 The external preparation for skin of the present invention can be used as a sunscreen cosmetic by blending metal oxide fine particles and an organic ultraviolet absorber.
金属酸化物微粒子としては特に限定されないが、微粒子酸化チタン、微粒子酸化亜鉛から選択される1種又は2種を用いることが一般的である。金属酸化物微粒子は、そのまま本発明の皮膚外用剤に配合することも可能であるが、シリコーン油、エステル油、水性成分に予め分散させたものを用いることも可能である。また、金属酸化物微粒子を板状粉体の表面に被覆した粉体及びかかる粉体を表面改質剤で改質した粉体を用いることもできる。 The metal oxide fine particles are not particularly limited, but it is common to use one or two kinds selected from fine particle titanium oxide and fine particle zinc oxide. The metal oxide fine particles can be blended as they are in the external preparation for skin of the present invention, but it is also possible to use those previously dispersed in a silicone oil, an ester oil, or an aqueous component. Further, a powder obtained by coating the surface of a plate-shaped powder with metal oxide fine particles and a powder obtained by modifying the powder with a surface modifier can also be used.
有機紫外線吸収剤の種類は特に限定されず、公知の有機紫外線吸収剤を制限無く使用できる。このような公知の有機紫外線吸収剤として、例えばパラメトキシケイ皮酸2−エチルヘキシル、メトキシケイ皮酸イソプロピル、メトキシケイ皮酸イソアミル等のケイ皮酸誘導体;パラアミノ安息香酸(以下、「PABA」と略記する)、エチルPABA、エチル−ジヒドロキシプロピルPABA、エチルヘキシル−ジメチルPABA、グリセリルPABA等のPABA誘導体;ホモサラート、エチルヘキシルサリチラート、ジプロピレングリコールサリチラート、TEAサリチラート等のサリチル酸誘導体;ベンゾフェノン−1、ベンゾフェノン−2、ベンゾフェノン−3またはオキシベンゾン、ベンゾフェノン−4、ベンゾフェノン−5、ベンゾフェノン−6、ベンゾフェノン−8、ベンゾフェノン−9、ベンゾフェノン−12等のベンゾフェノン誘導体;3−ベンジリデンショウノウ、4−メチルベンジリデンショウノウ、ベンジリデンショウノウスルホン酸、メト硫酸ショウノウベンザルコニウム、テレフタリリデンジショウノウスルホン酸、ポリアクリルアミドメチルベンジリデンショウノウ等のベンジリデンショウノウ誘導体;アニソトリアジン、ジエチルヘキシルブタミドトリアゾン、2,4,6−トリス(ジイソブチル−4’−アミノベンザルマロナート)−s−トリアジン、2,4−ビス−〔{4−(2−エチルヘキシルオキシ)−2−ヒドロキシ}−フェニル〕−6−(4−メトキシフェニル)−1,3,5−トリアジン、2,4,6−トリス〔4−(2−エチルヘキシルオキシカルボニル)アニリノ〕−1,3,5−トリアジン等のトリアジン誘導体;フェニルジベンゾイミダゾールテトラスルホン酸二ナトリウム等のフェニルベンゾイミダゾール誘導体;ドロメトリゾールトリシロキサン、メチレンビス(ベンゾトリアゾリルテトラメチルブチルフェノール)等のフェニルベンゾトリアゾール誘導体;アントラニル酸メンチル等のアントラニル誘導体;ジメトキシベンジリデンオキソイミダゾリジンプロピオン酸2−エチルヘキシル等のイミダゾリン誘導体;ベンザルマロナート官能基を有するポリオルガノシロキサン等のベンザルマロナート誘導体;1,1−ジカルボキシ(2,2’−ジメチルプロピル)−4,4−ジフェニルブタジエン等の4,4−ジアリールブタジエン誘導体;オクトクリレン、2−〔4−(ジエチルアミノ)−2−ヒドロキシベンゾイル〕安息香酸ヘキシル、4−tert−ブチル−4’−メトキシジベンゾイルメタンなどが挙げられる。有機紫外線吸収剤は1種を単独で又は2種以上を組み合わせて使用できる。 The type of the organic ultraviolet absorber is not particularly limited, and a known organic ultraviolet absorber can be used without limitation. Examples of such known organic ultraviolet absorbers include silicic acid derivatives such as 2-ethylhexyl paramethoxycinerate, isopropyl methoxycinnamate, and isoamyl methoxycinnamate; paraaminobenzoic acid (hereinafter abbreviated as "PABA"). PABA derivatives such as ethyl PABA, ethyl-dihydroxypropyl PABA, ethylhexyl-dimethyl PABA, glyceryl PABA; salicylic acid derivatives such as homosalate, ethylhexyl salicylate, dipropylene glycol salicylate, TEA salicylate; benzophenone-1, benzophenone -2, Benzophenone-3 or oxybenzophenone, benzophenone-4, benzophenone-5, benzophenone-6, benzophenone-8, benzophenone-9, benzophenone-12 and other benzophenone derivatives; Benzophenone sulphonic derivatives such as sulfonic acid, methosulfate benzophenone sulconium, terephthalilidene sulphonic acid, polyacrylamide methyl benzylene sulphonate; anisotriazine, diethylhexylbutamidotriazone, 2,4,6-tris (diisobutyl-4 '-Aminobenzophenone) -s-triazine, 2,4-bis- [{4- (2-ethylhexyloxy) -2-hydroxy} -phenyl] -6- (4-methoxyphenyl) -1,3 , 5-Triazine, 2,4,6-Tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-Triazine and other triazine derivatives; phenyldibenzoimidazole tetrasulfonate and other phenylbenzoimidazole Derivatives; phenylbenzotriazole derivatives such as drometrizoletrisiloxane, methylenebis (benzotriazolyltetramethylbutylphenol); anthranil derivatives such as menthyl anthranylate; imidazoline derivatives such as dimethoxybenzidyleneoxoimidazolidine propionate 2-ethylhexyl; benzal Benzophenone malonate derivatives such as polyorganosiloxane having malonate functional groups; 4,4-diarylbutadiene derivatives such as 1,1-dicarboxy (2,2'-dimethylpropyl) -4,4-diphenylbutadiene; octocrylene , 2- [4- (diethylamino) -2-hydroxybenzoyl] hexyl benzoate, 4-ter Examples thereof include t-butyl-4'-methoxydibenzoylmethane. The organic ultraviolet absorber may be used alone or in combination of two or more.
有機紫外線吸収剤を配合する場合の配合量は1〜20質量%が好ましい。1質量%未満では充分な日焼け止め効果を得ることができず、20質量%を超えるとべたつきや、皮膚への一次刺激性が高まるなど、使用感に悪影響を及ぼす。 When the organic ultraviolet absorber is blended, the blending amount is preferably 1 to 20% by mass. If it is less than 1% by mass, a sufficient sunscreen effect cannot be obtained, and if it exceeds 20% by mass, it has an adverse effect on usability, such as stickiness and increased primary irritation to the skin.
本発明の皮膚外用剤には、上述の必須成分、任意成分の他に、必要に応じて通常皮膚外用剤に配合される、油性成分、保湿剤、色素、界面活性剤、増粘剤、美容成分、香料、高分子物質、防菌防微剤、アルコール類、粉体、スクラブ剤、生体由来成分等を適宜配合することができる。 In addition to the above-mentioned essential ingredients and optional ingredients, the external preparation for skin of the present invention includes oily ingredients, moisturizers, pigments, surfactants, thickeners, and beauty agents that are usually added to external preparations for skin as needed. Ingredients, fragrances, polymer substances, antibacterial and microscopic agents, alcohols, powders, scrubbing agents, biological components and the like can be appropriately blended.
本発明の皮膚外用剤は、通常の製造方法により製造することができる。 The external preparation for skin of the present invention can be produced by a usual production method.
以下、実施例を挙げて本発明についてより具体的に説明する。ただし、本発明は以下の実施例に限定されるものではない。なお、配合量は、特に指定しない限り質量%を意味する。比較例については、対応する実施例に配合したホウケイ酸(Ca/Na)又は酸化亜鉛被覆ホウケイ酸(Ca/Na)を「全量を100とする量配合した成分」に置換したものを対応する比較例とした。また、実施例又は比較例は定法により調製した。 Hereinafter, the present invention will be described in more detail with reference to examples. However, the present invention is not limited to the following examples. The blending amount means mass% unless otherwise specified. As for the comparative example, the borosilicate (Ca / Na) or zinc oxide-coated borosilicate (Ca / Na) blended in the corresponding example was replaced with "a component blended in an amount of 100 in total" for the corresponding comparison. As an example. In addition, Examples or Comparative Examples were prepared by a conventional method.
実施例及び比較例の評価方法について述べる。
[べたつき]
前腕内側部をあらかじめ決められた石鹸を用いて洗浄し、前腕の水分をふき取る。左右前腕に2箇所ずつ3.0cm×3.0cmの領域を記し、実施例若しくは比較例を指サックをはめた指で隣り合わせに適量塗布し、下記の基準で合議により判定した。なお、官能評価専門員3名を被験者とした。
「○」:実施例のほうが、べたつきが少ない。
「△」:実施例、比較例が同等である。
「×」:比較例のほうが、べたつきが少ない。
[化粧持ち]
べたつきを評価したサンプルについて、4時間後の前腕内側部に残存している実施例又は比較例を目視で観察し、比較評価した。
「○」:実施例のほうが、残存量が多い。
「△」:実施例、比較例が同等である。
「×」:比較例のほうが、残存量が多い。
The evaluation method of Examples and Comparative Examples will be described.
[Stickiness]
Clean the inside of the forearm with a predetermined amount of soap and wipe off the water from the forearm. Two areas of 3.0 cm × 3.0 cm were marked on the left and right forearms, and an appropriate amount was applied next to each other with a finger cot in the example or comparative example, and the judgment was made by consensus based on the following criteria. The subjects were three sensory evaluation specialists.
"○": The example is less sticky.
"Δ": Examples and comparative examples are equivalent.
"X": The comparative example is less sticky.
[Makeup]
For the sample evaluated for stickiness, the examples or comparative examples remaining on the medial side of the forearm after 4 hours were visually observed and comparatively evaluated.
"○": The remaining amount is larger in the examples.
"Δ": Examples and comparative examples are equivalent.
"X": The comparative example has a larger residual amount.
ホウケイ酸(Ca/Na)としては、商品名「COVABEAD CRYSTAL」(SENSIENT COSMETIC TECHNOLOGIES社製;平均粒子径11μm)を、酸化亜鉛被覆ホウケイ酸(Ca/Na)としては、商品名「プルセア CBZ−NV」(鈴木油脂社製)をそれぞれ使用した。また、親水性高分子として以下の5種を使用した。
注1:PEMULEN TR−1(ルーブリゾール社製)
注2:SEPINOV EMT10(SEPIC社製)
注3:アデカノールGT−700(ADEKA社製)
注4:ケルコゲル HM(DSP五協フード&ケミカル社製)
注5:カーボポール940(ルーブリゾール社製)
As borosilicate (Ca / Na), the trade name "COVABEAD CRYSTAL" (manufactured by SENSIENT COSMETIC TECHNOLOGIES; average particle size 11 μm) is used, and as zinc oxide-coated borosilicate (Ca / Na), the trade name is "Pulsair CBZ-NV". "(Made by Suzuki Oil & Fat Co., Ltd.) was used respectively. In addition, the following 5 types were used as the hydrophilic polymer.
Note 1: PEMULEN TR-1 (manufactured by Lubrizol)
Note 2: SEPINOV EMT10 (manufactured by SEPIC)
Note 3: ADEKA NOL GT-700 (manufactured by ADEKA)
Note 4: Kerkogel HM (manufactured by DSP Gokyo Food & Chemical Co., Ltd.)
Note 5: Carbopole 940 (manufactured by Lubrizol)
表1、表2に 水中油型乳化リキッドファンデーションの処方例とその評価結果を示す。表1、表2に示した通り中実球状ホウケイ酸塩粒子を配合した実施例は、配合していない比較例よりべたつきの少ない良好な使用感であった。また、酸化亜鉛被覆中実球状ホウケイ酸を配合した実施例6〜10は、対応する比較例よりも化粧持ちが良好であった。 Tables 1 and 2 show formulation examples of the oil-in-water emulsified liquid foundation and their evaluation results. As shown in Tables 1 and 2, the examples in which the solid spherical borosilicate particles were blended had a better usability with less stickiness than the comparative examples in which the solid spherical borosilicate particles were not blended. In addition, Examples 6 to 10 containing zinc oxide-coated solid spherical borosilicate had better makeup retention than the corresponding comparative examples.
表3、表4に水中油型乳化日焼け止めの処方例とその評価結果を示す。表3、表4に示した通り中実球状ホウケイ酸塩粒子を配合した実施例は、配合していない比較例よりべたつきの少ない良好な使用感であった。また、酸化亜鉛被覆中実球状ホウケイ酸を配合した実施例16〜20は、対応する比較例よりも化粧持ちが良好であった。 Tables 3 and 4 show prescription examples of oil-in-water emulsified sunscreens and their evaluation results. As shown in Tables 3 and 4, the examples in which the solid spherical borosilicate particles were blended had a better usability with less stickiness than the comparative examples in which the solid spherical borosilicate particles were not blended. In addition, Examples 16 to 20 containing zinc oxide-coated solid spherical borosilicate had better makeup retention than the corresponding comparative examples.
表5に乳液の処方例とその評価結果を示す。表5に示した通り中実球状ホウケイ酸塩粒子を配合した実施例は、配合していない比較例よりべたつきの少ない良好な使用感であった。 Table 5 shows prescription examples of emulsions and their evaluation results. As shown in Table 5, the example in which the solid spherical borosilicate particles were blended had a better feeling of use with less stickiness than the comparative example in which the solid spherical borosilicate particles were not blended.
表6にクリームの処方例とその評価結果を示す。表6に示した通り中実球状ホウケイ酸塩粒子を配合した実施例は、配合していない比較例よりべたつきの少ない良好な使用感であった。 Table 6 shows a prescription example of the cream and its evaluation result. As shown in Table 6, the examples in which the solid spherical borosilicate particles were blended had a better usability with less stickiness than the comparative examples in which the solid spherical borosilicate particles were not blended.
表7に保湿ジェルの処方例とその評価結果を示す。表7に示した通り中実球状ホウケイ酸塩粒子を配合した実施例は、配合していない比較例よりべたつきの少ない良好な使用感であった。 Table 7 shows a prescription example of the moisturizing gel and its evaluation result. As shown in Table 7, the examples in which the solid spherical borosilicate particles were blended had a better usability with less stickiness than the comparative examples in which the solid spherical borosilicate particles were not blended.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019211417A JP2021080230A (en) | 2019-11-22 | 2019-11-22 | Topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019211417A JP2021080230A (en) | 2019-11-22 | 2019-11-22 | Topical skin preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021080230A true JP2021080230A (en) | 2021-05-27 |
Family
ID=75966124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019211417A Pending JP2021080230A (en) | 2019-11-22 | 2019-11-22 | Topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2021080230A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002020652A (en) * | 2000-07-13 | 2002-01-23 | Kao Corp | Composite powder |
JP2007077087A (en) * | 2005-09-15 | 2007-03-29 | Noevir Co Ltd | Pearlescent pigment |
JP2009019023A (en) * | 2007-07-13 | 2009-01-29 | Mandom Corp | Hair-dressing emulsified cosmetic |
JP2019019077A (en) * | 2017-07-18 | 2019-02-07 | ポーラ化成工業株式会社 | Skin external composition |
CN110339076A (en) * | 2019-07-19 | 2019-10-18 | 中山爱护日用品有限公司 | A kind of sunscreen composition and the preparation method and application thereof with broad-spectrum light protective action |
JP2019532969A (en) * | 2016-10-31 | 2019-11-14 | ロレアル | Water-in-oil emulsion that gives the skin a matte effect and true color |
-
2019
- 2019-11-22 JP JP2019211417A patent/JP2021080230A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002020652A (en) * | 2000-07-13 | 2002-01-23 | Kao Corp | Composite powder |
JP2007077087A (en) * | 2005-09-15 | 2007-03-29 | Noevir Co Ltd | Pearlescent pigment |
JP2009019023A (en) * | 2007-07-13 | 2009-01-29 | Mandom Corp | Hair-dressing emulsified cosmetic |
JP2019532969A (en) * | 2016-10-31 | 2019-11-14 | ロレアル | Water-in-oil emulsion that gives the skin a matte effect and true color |
JP2019019077A (en) * | 2017-07-18 | 2019-02-07 | ポーラ化成工業株式会社 | Skin external composition |
CN110339076A (en) * | 2019-07-19 | 2019-10-18 | 中山爱护日用品有限公司 | A kind of sunscreen composition and the preparation method and application thereof with broad-spectrum light protective action |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106659646B (en) | Sprayable sunscreen composition with oil droplets | |
EP2773314B1 (en) | Cosmetic composition | |
US20140105845A1 (en) | Cosmetic compositions comprising wax dispersions | |
JP5058353B2 (en) | Oil-in-water emulsion composition | |
EP2906195A1 (en) | Cosmetic compositions comprising wax dispersions | |
BR112015003963B1 (en) | WATERY WAX DISPERSIONS AND HAIR MODELING COMPOSITIONS CONTAINING THE SAME | |
WO2019065963A1 (en) | Oil-in-water-type emulsion cosmetic | |
TWI803531B (en) | Composition for anti-fine dust | |
WO2020090874A1 (en) | Emulsified cosmetic and method for producing same | |
AU2022203063B2 (en) | Foaming sunscreen composition containing an ultraviolet radiation-absorbing compound and a superhydrophilic amphiphilic copolymer | |
JP5819643B2 (en) | Composition for external use | |
JP5608366B2 (en) | Oil-in-water emulsified cosmetic | |
CN113747876A (en) | Cosmetic or personal care formulations containing porous metal oxide spheres | |
AU2016323836B2 (en) | Sunscreen compositions comprising superhydrophilic amphiphilic copolymers | |
JP2021080230A (en) | Topical skin preparation | |
JP2021080229A (en) | Topical skin preparation | |
JP4359281B2 (en) | Sunscreen cosmetics | |
JP2021080235A (en) | Topical skin preparation | |
WO2018015094A1 (en) | Cosmetic composition containing hydrophobic flakes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220726 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230613 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230803 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231011 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20231012 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20231128 |